Basel Medical Group (NASDAQ:BMGL – Get Free Report) and Establishment Labs (NASDAQ:ESTA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.
Profitability
This table compares Basel Medical Group and Establishment Labs’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Basel Medical Group | N/A | N/A | N/A |
| Establishment Labs | -43.45% | -235.45% | -22.83% |
Earnings and Valuation
This table compares Basel Medical Group and Establishment Labs”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Basel Medical Group | $8.90 million | 1.89 | -$9.50 million | N/A | N/A |
| Establishment Labs | $166.02 million | 12.11 | -$84.60 million | ($2.84) | -24.36 |
Basel Medical Group has higher earnings, but lower revenue than Establishment Labs.
Analyst Recommendations
This is a breakdown of current ratings for Basel Medical Group and Establishment Labs, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Basel Medical Group | 1 | 0 | 0 | 0 | 1.00 |
| Establishment Labs | 1 | 1 | 6 | 0 | 2.63 |
Establishment Labs has a consensus target price of $78.86, indicating a potential upside of 13.99%. Given Establishment Labs’ stronger consensus rating and higher probable upside, analysts plainly believe Establishment Labs is more favorable than Basel Medical Group.
Institutional and Insider Ownership
72.9% of Establishment Labs shares are owned by institutional investors. 11.1% of Establishment Labs shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Establishment Labs beats Basel Medical Group on 7 of the 11 factors compared between the two stocks.
About Basel Medical Group
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.
About Establishment Labs
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Receive News & Ratings for Basel Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basel Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
